Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan ^|^mdash;2012 Version
Tamio Teramoto(Institute for Atherosclerosis Research), Koutaro Yokote(Chiba University), Mami Iida(Gifu Prefectural General Medical Center), Makoto Kinoshita(Institute for Atherosclerosis Research), Shun Ishibashi(Jichi Medical University), Genshi Egusa(National Institutes of Health), Hiroyuki Daida(Juntendo University), Shinji Kihara(Osaka University), Sadatoshi Birou(Institute for Atherosclerosis Research), Junichi Sasaki(Institute for Atherosclerosis Research), Takao Ohta(Institute for Atherosclerosis Research), Takafumi Hiro(Institute for Atherosclerosis Research), Shizuya Yamashita(Osaka University), Kazuhiko Hirobe(Institute for Atherosclerosis Research), Masayuki Yokode(Kyoto University), Tomonori Okamura(Wakayama Medical University), Chizuko Maruyama(Japan Women's University), Seitaro Dohi(Mitsui Chemicals (Germany))
Cited by 469
Related Papers
Cardiovascular Disease and Risk Factors in Asia
|Circulation|2008|916
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
|Journal of Atherosclerosis and Thrombosis|2018|821
Adiponectin, Metabolic Risk Factors, and Cardiovascular Events among Patients with End-Stage Renal Disease
|Journal of the American Society of Nephrology|2002|761
Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice.
|Journal of Clinical Investigation|1994|723
A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen
|Journal of Human Hypertension|2002|722